Skip to main content

Table 1 Baseline clinical and laboratory characteristics and the number of subjects with various outcomes according to P wave duration among type 2 diabetes patients

From: Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease

 

P wave duration

 

Variables

<114 ms

≥114 ms

P

N

569

170

 

Age (years)

57.5 ± 5.29

59.0 ± 4.21

0.001

Duration of diabetes (years)

7.9 ± 3.9

8.0 ± 3.9

0.649

Total cholesterol, mmol/L

6.68 ± 1.66

6.81 ± 1.98

0.381

HDL cholesterol, mmol/L

1.25 ± 0.363

1.19 ± 0.310

0.051

Triglycerides, mmol/L

2.38 ± 2.58

3.10 ± 4.08

0.006

Glycosylated hemoglobin A1, %

9.90 ± 2.39

10.1 ± 1.93

0.257

BMI, kg/m2

29.0 ± 5.23

30.2 ± 5.13

0.007

Urinary protein, mg/L

220 ± 445

396 ± 879

0.001

Physical activity, MET†

4.1 ± 1.9

3.85 ± 1.8

0.091

Heart rate, bpm

74 ± 13

75 ± 15

0.368

Women, %

50.6

41.2

0.031

Current smokers, %

16.7

17.6

0.772

Hypertension/-medication, %

56.6

74.7

<0.001

Systolic BP, mmHg

153 ± 23

157 ± 23

0.036

Diastolic BP, mmHg

85 ± 12

88 ± 12

0.005

Alcohol users, %

35.9

43.5

0.070

Area of residence, Turku, %

51.8

48.8

0.489

LVH, %

12.3

16.5

0.160

PNMMVD*, %

52.7

70.0

<0.001

Diabetes treatment

  

0.823

diet only, %

13.5

14.7

 

oral drugs, %

74.2

71.8

 

insulin therapy, %

12.3

13.5

 

Death rates/1000-patient-years

   

Total mortality

52.9

64.7

0.039

CVD mortality

33.7

43.5

0.070

CHD mortality

24.7

30.3

0.326

Stroke mortality

5.7

9.1

0.153

  1. Data are expressed as the mean ± SD, unless otherwise indicated.
  2. *Prevalent non-major macrovascular disease (ischaemic ECG changes and typical symptoms of angina pectoris, or claudication), †Metabolic equivalent task.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us